Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reexam Terminated - Notice of Intent to Issue a Reexamination Certificate Mailed

The MMP revenue stream itself is inconsistant and the confidentiality issues are of no benefit whatsoever. At the least, an opportunity was squandered by not forcasting qtly revenue guidance from qtr. to qtr. Also the company's ability to have control of its revenue stream is equally at fault..........Predictability and certainty are key elements IMO........

Share
New Message
Please login to post a reply